Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (YDO1)

Market Closed
3 Jun, 20:00
XSTU XSTU
390. 10
+0.6
+0.15%
- Market Cap
- P/E Ratio
- Div Yield
130 Volume
-19.39 Eps
389.5
Previous Close
Add Transaction
Day Range
384 390.1
Year Range
235.6 519.6
Want to track YDO1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
30 Apr 2026
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
26 Feb 2026
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
29 Oct 2025
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
5 Aug 2025
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
5 May 2025
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
26 Feb 2025
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
4 Nov 2024
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
6 Aug 2024
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
7 May 2024
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
21 Feb 2024
-
-
Madrigal Pharmaceuticals, Inc. logo
YDO1 Madrigal Pharmaceuticals, Inc.
1 Nov 2023
-
-

YDO1 Earnings Reports FAQ

What is the earnings per share (EPS) for YDO1?

The current EPS is -19.39.

What is the company's earnings growth rate?

Madrigal Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Madrigal Pharmaceuticals, Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Madrigal Pharmaceuticals, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for YDO1 at this time, as Madrigal Pharmaceuticals, Inc has no recent EPS data to calculate it.